Ads
related to: Pfizer
Search results
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 3 days agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 3 days agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...
Pfizer’s reported net income declines 44% in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 2 days agoPfizer’s reported net income stood at $3.11bn in the first quarter (Q1) of 2024, marking a decrease of 44% from $5.54bn posted in Q1 2023. The...
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 3 days agoWhile the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed...
Pfizer Q1 earnings: non-Covid product sales help post revenues of $14.9 billion despite Comirnaty,...
Invezz· 3 days agoPfizer Inc. has announced its financial outcomes for the first quarter of 2024, displaying strong...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 4 days agoI owned shares of Pfizer (NYSE: PFE) when the COVID-19 pandemic started. Watching the stock soar...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 2 days agoPfizer stock surged Wednesday after the pharma giant walloped analysts' first-quarter earnings...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 3 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
What's Going With Pfizer Stock On Wednesday? - Pfizer (NYSE:PFE)
Benzinga· 3 days agoOn Wednesday, Pfizer Inc. PFE reported first-quarter adjusted EPS of $0.82, down 33% year over year,...
Pfizer Shares Jump After Beating Estimates
The Wall Street Journal· 2 days agoPfizer shares rose more than 6% Wednesday afternoon after the company's first-quarter results beat Wall Street analyst estimates and the drugmaker raised...